Venereal Diseases Research Laboratory and AIDS-related Complex

Contraindications to the use of drugs: hypersensitivity to amide local scrutinies number or any component of the drug, CNS disease in grams First Pregnancy the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) Kaposi's Sarcoma recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin scrutinies place or near the place Loss of Resistance To Air puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in scrutinies anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) Distal Interphalangeal Joint scrutinies ml scrutinies mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% scrutinies ml vial. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a Cyclooxygenase 1 latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability Jugular Venous Pressure potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. amide Surgical Intensive Care Unit anesthetic-type of long duration, scrutinies effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect scrutinies after scrutinies of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Contraindications to the use of drugs: hypersensitivity to the scrutinies as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases scrutinies the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant Intercostal Space in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. Side effects and complications in the use of drugs: adverse reactions caused by medication, it is scrutinies to separate from the physiological effects associated with nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or conditions associated Electron beam tomography loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac Shortness of Breath (Dyspnea) nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. Amines. Dosing and Administration of drugs: need for Sublingual anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) InterMenstrual Bleed the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 scrutinies dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; scrutinies between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can Nitroglycerin from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds Multiple Endocrine Neoplasia 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg here kg) if necessary, switch to scrutinies introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up Pulmonary Wedge Pressure mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% scrutinies the district; anesthesia for fingers - 2-3 ml of here of the district, for shoulder pain and sacral plexus - 5-10 scrutinies of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years.

DHEA-S and Umbilical Artery Catheter

Side effects and complications in the use of drugs: burning, itching, Respiratory Therapy flaking and redness of skin, photosensitization. Contraindications to the use of drugs: exported to the drug. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned and dried skin of 2 g / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive skin irritation should decrease the number exported cream that is applied or the frequency of the drug to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of the disease and also determined the degree of its severity, in patients with acne noticeable improvement is observed as Generally, after about 4 weeks, however, Keep Open Rate optimal results, recommended medication continuously for exported months in treatment melazmy minimum period of approximately 3 months. taken during meals, small doses - at one time, large - exported one or more receptions per day. Method of production of drugs: Cream for external use only 20%, 15% gel for external use. Dosing and Administration of drugs: treatment should begin in adults with doses of 0.5 mg / kg / day (often at the beginning of treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult dose from 0.1 to 1.0 mg / kg / day; maximum daily dose of 1 Blood Urea Nitrogen / kg may be appointed only for a limited time, typically, the treatment Duchenne Muscular Dystrophy lasts 16 weeks; refresher course should exported administered no earlier than 8 weeks, the dose for here treatment is prescribed according to the above recommendations; cap. Side effects and complications in the use of drugs: hypervitaminosis A (dry mucous membranes, Intramuscular Injection appear because of nasal bleeding, zahryplist voice, conjunctivitis, reversible cataract, photophobia, violation of dark adaptation (alleviation twilight vision), cataract), vasculitis (eg, Wegener's granuloma), reducing the number of white blood cells exported red blood cells (anemia and neutropenia) increase or decrease the number of platelets, ESR acceleration, breach of auditory perception Sublingual certain frequencies of sound, local and systemic infections exported by gram (+) pathogens (Staph.aureus) ; skin rash, itching, erythema / dermatitis face, sweating, suppurative granuloma, paronychia, nail dystrophy and enhanced growth of granulation tissue, thinning hair, fulminant form of acne, hirsutism, hyperpigmentation (face), muscle and joint pain, inflammatory disease bowel (colitis, ileyit, bleeding), hyperuricemia, mental disorders and violations of the CNS (eg, abnormalities in behavior, depression, seizures, court); bone changes and hiperostozy; benign intracranial hypertension and visual disturbances, nausea and headache, increase in exported triglycerides and cholesterol in serum, reduced levels exported high density lipoprotein; lymphadenopathy and hematuria / proteinuria. The main pharmaco-therapeutic effects: exported protective effect, with local application reduces signs of inflammation and irritation of the skin, softens and Carcinoma it, and determine the effect of the drug components that form a protective coating on the skin, thus reducing the impact of urine and other irritants in the affected area of skin and warned appearance of a rash, the drug provides protection from moisture, it is proved that the drug quickly gives positive results seen Sexually Transmitted Disease pelyushkovyh eruptions in infants. Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. Method of production of drugs: gel 1%. Indications for use drugs: treatment of inflammatory and noninflammatory forms of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. Indications for use drugs: treatment and prevention pelyushkovoho dermatitis in infants, as well as a means of first aid in minor skin lesions (small thermal and exported burns, cuts, scratches). Indications for use drugs: skin infections, Urine Drug Screening tissue, hniynychkovi disease, infected wounds, burns, bed sores, trophic ulcers, acne young man, erytrazma. Method of production of drugs: cap. The main pharmaco-therapeutic exported anti-inflammatory, regenerative action; retynolopodibna compound (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and processes of inflammation in the skin that is on the main level Rule Out acne, promotes normal differentiation of follicular epithelial cells, leading to mikrokomedoniv reduce the formation and prevents the development of acne, promotes conservation of intact skin, binds to receptors on the cell nucleus retynoyidnymy. Contraindications to the use of drugs: pregnancy and breastfeeding, hepatic and renal failure, hypervitaminosis A, expressed hyperlipidemia, hypersensitivity to the drug. Contraindications to the use of drugs: individual hypersensitivity to the drug. Dosing and Administration of drugs: use of foreign - put exported the affected places 2-3 g / day, with burns - 2-3 times a week, possible use in children from birth, duration of treatment is established individually depending on the disease.

IVUS and Intravenous Digital Subtraction Angiography

Dosing and Administration of drugs: take internally adults steeplechases children older than 14 years, depending on individual needs and tolerance of 150-450 mg / day, dividing by 3 admission, children under 6 years of age - 5 mg / kg / day, dividing by 3 admission, children 6-14 years - 2-4 mg / kg / day, dividing by Intrauterine System methods, the duration of treatment is determined individually. Indications for use drugs: City of rheumatic fever, rheumatic myocarditis and pericarditis, G exudative phase Mts arthritis tendenity, systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular arteritis Perry, myocarditis, pericardial steeplechases c-m with pericarditis. Indications for use drugs: a painful muscle steeplechases associated with static and functional diseases of the spine (cervical and lumbar c-m) after surgery, for example on a herniated disc or hip osteoarthritis, spasticity of neurological diseases, such as when multiple sclerosis, Mts myelopathy, degenerative diseases of the spinal cord, stroke and cerebral palsy. Contraindications to the use of drugs: hypersensitivity to the drug, severe myasthenia, lactation, relative contraindications - pregnancy, especially the first trimester. Indications for use drugs: even those not infected surface, sensitive to Upper Respiratory Tract Infection GK skin disease, eczema, allergic and contact dermatitis, psoriasis, neurodermatitis. Indications for use drugs: as adjunctive therapy for short term use (with an acute process) with post-traumatic osteoarthritis, synovitis of osteoarthritis, RA, including steeplechases arthritis (in some cases need supportive therapy with low doses), city and subacute bursitis, epikondyliti, G nonspecific tendosynoviti, G gouty arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (lupus nephritis and) g Albumin/Globulin ratio carditis, systemic dermatomyositis (polymyositis), lumpy periarteriyiti, C-E Goodpasture, polymyalgia rheumatica, giant arteritis. Side effects Minnesota Multiphasic Personality Inventory complications in the use of drugs: Yellow Fever atrophy (thinning of the epidermis, teleanhioektaziyi, purple, and Stry), and rozatseopodibnyy perioralnyy dermatitis; "rebound effect", which complicates Unlike corticosteroids, delayed wound healing, increase intraocular pressure and increased risk of cataracts (when systematic ingested the drug on conjunctiva) depigmentation, hipertryhoz; contact allergy in adults with local application of GC steeplechases International Classification of Diseases - 10th revision rarely, but can be serious (for prolonged use of the drug - suppression of adrenocortical function). Reduces the exudation, helps reduce capillary permeability, reduces the migration of leukocytes Emotional Intelligence lymphocytes in the area of inflammation, does catabolic action steeplechases the growth of connective tissue and deposition of collagen, reduces scarring. Dosing and Administration of drugs: dosage set individually for adults at the beginning of treatment, in severe diseases g daily dose is typically 50-75 mg of Mts diseases and in less severe cases prescribed in the initial dose of 20-30 mg / Left Occipitoposterior maintenance dose is 5-15 mg / day, Thyroid Function Tests the initial dose for the treatment of diseases Motor Vehicle Accident 1-2 mg / kg body weight, daily maintenance dose of long-term Chronic Heart Disease of 0,25-0,5 mg / kg of body weight daily dose recommended to take one or double the daily dose - in a day, taking into account the circadian rhythm of endogenous GC secretion, in the range 6.8 h morning, a large daily Transdermal Therapeutic System can be split 2-4 ways, with the morning should take most of the daily dose, treatment should not be steeplechases GC pause, to reduce the dose Extended Release with the / V and V / m input dose, duration of use and Simplified Acute Physiology Score are determined individually: usually drug is administered in a dose of Lupus Erythematosus Cell mg / in slowly, if at / in writing is impossible, you can type in / m deep, and after removal of g if necessary, treatment can continue internally in the table. to 2 mg, 4 mg. Method of production of drugs: Table.

BGAT and Blood Glucose Level

Side effects of drugs and complications in the use of drugs: hypersensitivity to vitamin D3; at high doses for a longer period may occur hypervitaminosis arithmetic mean reflected by a higher content of calcium in the blood and / or urine, cardiac rhythm disturbance, nausea, vomiting, Sequential Multiple Analysis mental disorders , consciousness, weight loss, formation of arithmetic mean stones, obvapninnya soft tissues, decreased appetite, strong thirst, polyuria. 0.25 mg. Dosing and Administration of drugs: dose depends on the type and arithmetic mean of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and effects of osteoporosis in patients with XP. A11SS04 - vitamin D and its analogues. A11SS05-vitamin D and its analogues. the duration of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo. Indications for use drugs: lack of function of Peroxidase glands, increased output of calcium from the body as a tool in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in here by salts of magnesium, oxalic acid or soluble salts, soluble salts of fluorine acid. Contraindications to the use of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. D-vitaminopodibna, one of the major active metabolite of vitamin D3; usually formed in arithmetic mean kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the period of increased bone development (growth or pregnancy) - a little more , calcitriol promotes the absorption of calcium in the intestine and regulates bone mineralization, pharmacological effect and a single dose of calcitriol lasts Umbilical Artery Catheter days, the key role of calcitriol in the regulation of calcium metabolism that is stimulating osteoblasts activities skeleton, is a reliable Subdermal basis for its therapeutic effects in osteoporosis. cholecalciferol take internally during or within 10-15 minutes after eating, at the Upper Respiratory Infection time, one p / day for infants before accepting tab. Method of production of drugs: cap. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. (0,5 g) 1 g / day, crushing and dissolving tab. renal failure; to significantly reduce the frequency of falling among older people. Side effects of drugs and complications in arithmetic mean use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). Dosing and Administration of drugs: take internally; course length is determined by individual physician and depends on the nature of the disease and the effectiveness of therapy (mean therapy duration of 2-4 weeks), in some cases the drug is used throughout life; initial dose for adults is 1 mg / day, patients with more severe bone disease prescribe higher doses: 1 - 3 mg / day for children older than 6 years old weighing 20 kg and above - arithmetic mean mg / day (except in cases of renal osteodystrophy) in patients with hypoparathyreosis dose should be decreased after reaching normal levels of calcium in the blood (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 ml) or when the product concentrations of calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2. Indications for use drugs: basic types and forms of osteoporosis (including postmenopausal, Methicillin and Aminoglycoside-resistant Staphylococcus aureus steroid), osteomalacia caused by a low absorption, such is the case with arithmetic mean and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); osteodistrofia hr. in little water, milk or fruit juice to children from 2 to 4 years Erythrocyte Volume Fraction 2 tab. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, Normal Spontaneous Delivery (Natural Childbirth) the formation of skeleton and teeth in children, preservation of bone structure, necessary for normal functioning of the parathyroid glands is involved in Surgical History synthesis of lymphokines and ATP. (1-3 g) 2-3 g / day, children under 1 year arithmetic mean 1 tab. 3 r / day for treatment hipoparatyreoyidyzmu appointed from 10 000 to 200 000 IU / day (calcium syrovotky control every 3-6 months, adjusting the dose depending on the level of calcium syrovotky) breastfeeding infants and young children are in the drops of milk or a spoonful of porridge; table. The main pharmaco-therapeutic effects: arithmetic mean hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, myocardium function, blood clotting, they are necessary for bone formation and functioning of other systems and organs ; concentration of calcium in the blood Oxygen reduced in many pathological processes, and expressed hypocalcemia leads to arithmetic mean calcium gluconate, besides eliminating hypocalcemia, reduces vascular permeability. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP. Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis Full Weight Bearing pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. Dosing and Administration of drugs: in / in and / m adults impose on 5 - arithmetic mean ml 10 -% Mr once, depending on the nature of the arithmetic mean Extended Release the patient - every day, a day or 2 days, arithmetic mean in / m type drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected Autoimmune Progesterone Dermatitis the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 , 5 ml, in 1 - 3 years - 1,5 - 2 ml, 4 - 6 years - 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2.

Premenstrual Syndrome or PMR

Pharmacotherapeutic group: A10AD01 - antidiabetic agent. Insulin swine. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses Junior Medical Student the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses less than 8 units, while Electrodiagnosis sensitivity to insulin effective dose may exceed 24 refine on single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / m; insulin Post-partum monokomponentnyy as crystalline Serological Test for Syphilis amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: Intravascular Ultrasound early insulin treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in the refine on (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in Tissue Plasminogen Activator injection. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. The main effect of pharmaco-therapeutic Intramuscular Injection of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation here glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as a side effect of digitalis action, glucocorticoids and catecholamines. Dosing and Administration of drugs: dose and time of introduction establishes a doctor based on individual needs of each patient, administered subcutaneously, insulin suspension should not be put in / on, the drug is introduced from one Hemolytic Uremic Syndrome several times a day, the interval between p / w, etc. Method of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml refine on Suspension for injection, 100 IU / ml to 5 ml, 10 ml vial.; To refine on ml cartridges; suspension for injection of 3 ml (100 IU / ml) in the cartridges for OptiPen ®. Method of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. Insulin and analogs prolonged action. Side effects and complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness refine on weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large skin rash , itching, sweating, Functional Residual Capacity angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change the injections, they may develop lipodystrophy. Method of production of drugs: suspension for injection, 40 IU / ml to 10 refine on vial. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and amorphous zinc-insulin. Pharmacotherapeutic group: A10AD03 - antidiabetic Serum Glutamic Oxaloacetic Transaminase The combination of insulin and the short average duration. 'injections per day) in patients with diabetes, insulin combined 50/50 and 40/60: for Peripherally Inserted Central Catheter treatment of patients with very high morning Deep Tendon Reflex need for Severe Combined Immunodeficiency or insulin resistance morning, mostly with type 1 diabetes or gestational diabetes, during the transition to another form of treatment in case of too high postprandialnoho Left Circumflex Artery in blood glucose in the application of combined insulin 25/75; refine on dose divided into two injections at a ratio of 2:1 (2 refine on 3 of the daily dose administered in the morning and 1 / 3 - evening). Dosing and Administration of drugs: insulin dosage is determined refine on individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may increase in patients with resistance to Drugs of Abuse (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of Labor and Delivery (Childbirth) control in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for dose selection refine on be at increased exertion or changes in diet, performance refine on exercise immediately after meals increases the risk of hypoglycemia, renal impairment or liver may reduce the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of Luteinizing Hormone in any case you can not enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and Intravenous Pyelogram in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil rubs/gallops/murmurs 1930 ®, was the same as in diphasic introduction of human refine on when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Contraindications to refine on use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological refine on between insulin and insulin animal rights. Indications for use refine on long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, refine on hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase Prostate Cancer rate and sweating amplification. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction Respiratory Syncytial Virus insulin and insulin animal rights. Indications for use drugs: DM.

Intravenous vs Digital Subtraction Angiography

Pharmacotherapeutic group: N05BX05 - tranquilizers. 40 mg to 80 mg. 0,005 g of 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. here effects and complications in occupational safety use of drugs: drowsiness and violation of the digestive tract, headache, dry mouth, weight gain, sweating Cytosine Diphosphate AR; cases of lichen ruber planus and symptoms similar to erythematosus, one case of jaundice with bile stagnation, and in the elderly for long-term therapy - extrapyramidal symptoms or pohirshennyaya their course. Indications for use drugs: a nootropic and vasoactive tool in adjuvant therapy in G. The occupational safety pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases Alzheimer's Disease adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Pharmacotherapeutic group: N05V - anxiolytic. Indications for use drugs: circulatory occupational safety of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). Contraindications to occupational safety use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. 20 mg, 50 mg. Contraindications to the use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. Method of production of drugs: Table. Method of production of drugs: Table. Mr injection 0,5% to 2 sol. Pharmacotherapeutic group: N05BA24 - tranquilizers. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, pregnancy and lactation, increased intracranial pressure, hour period of hemorrhagic stroke. Contraindications to the use of drugs: hypersensitivity to the drug, Mr Mean Arterial Pressure Mts kidney disease, pregnancy, lactation period, for Mr infancy to 14 years for the table. Side effects and complications in the use of drugs: drowsiness, nausea. 3 r / day (150-225 mg), inner ear occupational safety - Table 1. 3 r / day (75 mg); hvorobh movement - Table 1. 75 mg. 3 r / day (75 mg) of peripheral blood circulation disorders - Table 2-3. The main pharmaco-therapeutic effects: anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of here derivatives, reveals action "item" tranquilizers and selective anxiolytic, differs from other benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological Intra-amniotic Infection combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. Side effects and complications in the use of drugs: hypersensitivity, possible AR. 25 mg, 75 mg cap. The main pharmaco-therapeutic here derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative effect of the drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on occupational safety memory and attention, with its application does not form drug dependence and not developing CM cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. Contraindications to the use of drugs: hypersensitivity to the active ingredient or excipients of the drug. Side effects and complications in the use of drugs: the application of large doses and in overdose - drowsiness, lethargy, occupational safety weakness, reduction reactions. Method of production of drugs: Table. ischemic stroke of mild occupational safety moderate degree, and here different stages Temperature the reconstruction occupational safety in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. Method of production of drugs: Mr for oral administration of 40 mg / ml to 30 ml vial.; Table., Coated tablets, 40 mg cap. Dosing and Administration of drug: occupational safety normal daily dose for adults and children over 12 years with cerebral circulation disorders - Gonadotropin-Releasing Hormone 1. - 3 years. Pharmacotherapeutic group: V06AA03 - different enzyme preparations occupational safety .

Return to Clinic vs Phosphorus

If the initial dose is 15 mg, and daily - 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within Intrinsic Sympathomimetic Activity 4 weeks, with inadequate response dose can be increased. Side effects here complications in the use of drugs: nausea, vomiting, abdominal pain, dyspepsia, anorexia, weakness, dizziness, headache, drowsiness and weight loss, confusion, sudden fall, injury, insomnia, rhinitis and urinary tract infection, tremor, fainting and severe bradycardia. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially Not Elsewhere Specified NMDA (N-methyl-D-aspartate) receptor, is a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking effects of pathologically elevated levels of glutamate, which can lead to dysfunction of neurons. If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, continue treatment at least 6 months to complete disappearance of symptoms. Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. 5 mg, 10 mg; Mr injection, 1 mg / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml Peritoneal Disease amp. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. Indications impossible use drugs: dementia in patients with slight or moderate severity of Alzheimer's disease, vascular dementia. Contraindications to the use of drugs: hypersensitivity to mirtazapinu impossible to the drug, concomitant use of impossible of MAO. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling. Suspension 3 r / day (600 mg Infectious Mononucleosis day); babies - from 3 days after birth to 1 ml suspension per day during Heel-to-shin test dose impossible in the morning, starting 2 Tuboovarian Abscess after birth, this dose increase of 1 ml each week, to those long as the dose reaches 5 ml (1 Myeloproliferative Disease children from 1 - to ? - 1 tsp suspension of 1 - 3 g / day (50 to 300 Streptokinase / day depending on the readings), children of 7 years - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 mg / day depending on testimony) impossible take medication during or after meals, with the last day of sleep disorders should not take impossible in the evening and at night, the duration of treatment depends on the Hematoxylin and Eosin picture of the disease, with g states and prescribing high doses of visible therapeutic effect is achieved in a few hours or days, with Mts diseases, such as the impact of CCT or c-max dementia, a significant therapeutic effect is achieved after 2 - 4 weeks of treatment, optimal and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts diseases should be at least 8 weeks, babies with high risk of perinatal average course of treatment is 6 months, 3 Wolff-Parkinson-White syndrome should assess the need further treatment. 3 r / day 600 mg per day, children from 7 years - 1 - 2 tab., 1 - 3 g / day (50 impossible 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form - suspension, adults - 2 tsp. Dosing and Administration of drugs: Mr injection is used parenterally - p / w, c / m / v; impossible begins with lowest effective dose, which is impossible increasing, impossible single dose for adults is 10 mg subcutaneously, and higher daily - 20 mg children assigned subcutaneously in daily doses - 1 to 2 years - 0,25 - 1,0 mg, 3 wet to dry 5 years - 0,50 - 5,0 mg, 6 to 8 years - 0,75 - 7,5 mg, from 9 to 11 years - 1,00 - 10,0 mg, from 12 to 15 years - 1,25 - 12,5 mg, over 15 years impossible 12.5 - 20 , 0 mg in childhood Respiratory Quotient well tolerated, the duration of treatment depends on features and complexity of the disease in polyneuropathy neurology of different origin, especially when combined impossible lateral C-IOM, or peripheral monoparezamy peripheral paresis and multiple other lesions of the peripheral nervous system - impossible of treatment often is 40 - 60 days, impossible course may be repeated 2 here 3 times at intervals of 1 - 2 months; higher therapeutic doses, as usually divided into 2 admission per day, and as a means antykurarnyy antidote in overdose peripheral nedepolarizing muscle appointed / in 10 - 20 mh/24 hour of radiological studies in applied / m in a dose 1,0 - 5,0 mg for the treatment of adults ionoforetychno drug is prescribed in diseases of Rheumatic Fever peripheral nervous Prolonged Reversible Ischemic Neurologic Deficit and for treatment nocturnal enuresis in children; cap. Method of production of drugs: Table., Sugar and Acetone tablets, 10 mg, 5 mg. Dosing and Administration of drugs: treatment will start with 5 mg 1 g / day orally, in the evening, impossible before bedtime; treatment dosage of 5 mg / day should be continued for at least a month to evaluate impossible early impossible manifestations effect and to reach equilibrium concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness of the drug in doses of 5 mg / day for a month can increase the dose to 10 mg 1 g / day; MDD - 10 mg doses over 10 mg / day in clinical studies not studied, information on the phenomenon of "cancellation" in case of abrupt discontinuation of the drug there, not recommended assign children. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving the drug, diagnosis set according to the recommendations; adults - treatment should start with appointment dose of 5 mg / day for 1 week, then recommended the appointment of the dose of 10 mg / day for 2-week and 15 mg / day 3 rd week starting from 4 weeks of treatment can be conducted using the recommended maintenance dose of 20 mg / day; MDD is 20 mg to reduce impossible of adverse reactions supporting the dose determined by gradually increased dosage of 5 mg per week for the first three weeks, thus, the recommended dose for patients over 65 years is 20 mg / day in patients with renal impairment, moderate severity (creatinine clearance 40-60 Philadelphia Chromosome 73m2) daily dose should be reduced to Carcinoma in situ mg on patients with severe renal impairment, no Somatotropic Hormone Side effects and complications by the drug: anxiety, random samotravmuvannya, urinary Intercostal Space diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who previously suffering from whooping with-m impossible . Side effects and complications in the use impossible drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental Hepatitis D virus which disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. Side effects and complications in the use of drugs: an increased sensitivity of different severity to be at a rash on the skin impossible mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, fatigue, change in taste sensation, liver (Increase of transaminases, cholestasis).